Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure allows for selective binding in biological systems, making it valuable in medicinal chemistry. The trimethylsilyl and ethynyl groups facilitate coupling reactions in organic synthesis, enabling the construction of complex molecules. Additionally, it serves in research settings for modifying peptide-like structures to enhance metabolic stability and bioavailability.